Print

Takara Bio Obtains Clinical Trial Approval Of Gene Therapy Treatment For Chronic Granulomatosis  
1/17/2007 12:15:16 PM

Tokyo, Jan 11, 2007 (JCN) - Bio affiliate ViroMed Co., Ltd., based in Korea, announced the Korea Food & Drug Administration approval of their clinical trial of VM106, gene therapy treatment drug, for chronic granulomatosis.
//-->